There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that ...

Glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) agonists — originally developed to treat people with ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

You will be redirected to our submission process. GLP-1 receptor agonists have gained popularity due to their dual benefits in managing Type-II diabetes and promoting significant weight loss. The ...